AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Basaglar 100IU/ml Kwikpen

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Insulin Glargine (100IU/ml)

Overview Basaglar 100IU/ml Kwikpen

KwikPen Basaglar (100 IU/ml) is a long-acting insulin formulation indicated for managing type 1 and type 2 diabetes in pediatric and adult patients. It delivers consistent insulin levels throughout the day, effectively regulating blood glucose and mitigating diabetes-related complications. Basaglar KwikPen may be administered solo or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Adherence to the prescribed dosage is crucial for optimal therapeutic outcomes; discontinuation may lead to dangerously elevated blood sugar levels. This medication forms part of a comprehensive diabetes management plan encompassing dietary adjustments, physical activity, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is the most frequently reported adverse event; accurate dosing, regular meals, and consistent blood glucose monitoring are vital for its prevention. Excessive alcohol consumption also increases hypoglycemia risk. Additional common side effects encompass peripheral edema, lipoatrophy/lipohypertrophy, hypersensitivity reactions, injection site reactions, pruritus, skin rashes, and weight increase. Avoid use if hypoglycemic. Pre-treatment disclosure of any pre-existing kidney, liver, or cardiac conditions is essential. Consult your physician before initiating Basaglar KwikPen if pregnant or breastfeeding.

Primary Ingredients of Basaglar 100IU/ml Kwikpen

No information provided. Please provide the text you want me to rewrite.

Uses of Basaglar 100IU/ml Kwikpen

High blood glucose

Major Benefits of Basaglar 100IU/ml Kwikpen:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Basaglar 100IU/ml Kwikpen:

  • Hypoglycemia (low blood glucose level)
  • Peripheral edema
  • Lipodystrophy (skin thickening or pits at the injection site)
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Rash
  • Weight gain

How to use Basaglar 100IU/ml Kwikpen:

Medical professionals will instruct you on the proper administration of this medication.

How Basaglar 100IU/ml Kwikpen works:

KwikPen Basaglar, a 100 IU/mL formulation, offers extended insulin action for stable blood glucose management throughout the day. Mimicking the body's natural insulin, it promotes glucose uptake by muscle and fat tissues while simultaneously reducing hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Mixing Basaglar 100IU/ml Kwikpen and alcohol is unsafe.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Basaglar 100 IU/mL KwikPen is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; clinical data in humans, however, remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Using Basaglar 100 IU/ml KwikPen while breastfeeding is likely safe. Available data from human studies indicate minimal risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Basaglar 100 IU/ml KwikPen. Dosage modification of Basaglar 100 IU/ml KwikPen may be necessary. Physician consultation is advised. Consistent blood glucose monitoring is recommended to guide dosage adjustments.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Basaglar 100 IU/mL KwikPen. Dosage modifications may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage adjustments.

What if you forget to take Basaglar 100IU/ml Kwikpen :

Should you forget a Basaglar 100IU/ml Kwikpen injection, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed injection and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Basaglar 100IU/ml Kwikpen

LabelValue
Chemical Type Modified insulin
Developing Habits No.
Treatment Category Diabetes Management
Behavioral Class Long-acting insulin analogs

FAQs on Basaglar 100IU/ml Kwikpen

Basaglar KwikPen (100 IU/mL) is a long-acting insulin analog closely resembling human insulin. Its consistent effect on blood sugar lasts approximately 24 hours, allowing for once-daily administration. It's indicated for treating type 1 and type 2 diabetes in adults, and type 1 diabetes in children.
Basaglar 100IU/ml KwikPen is injected subcutaneously. Your doctor will teach you the proper injection technique and suitable injection sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area for each dose; for example, if using your abdomen, inject about 1cm from the previous injection. Alternate injection sides daily (e.g., right side one day, left the next). This helps prevent complications like lipodystrophy (fat tissue thickening), irritation, and pain from repeated injections in the same spot. After one to two weeks, rotate to a different body area as instructed by your doctor. Contact your doctor if you experience any injection-related problems.
Basaglar KwikPen (100 IU/mL) is a once-daily, long-acting insulin. While it can be administered at any time, consistency is recommended—take it at the same time each day.
Taking more Basaglar 100IU/ml Kwikpen than prescribed can cause dangerously low blood sugar (hypoglycemia), ranging from mild to severe. Closely monitor your blood sugar for 24 hours. Mild hypoglycemia, with symptoms like anxiety, sweating, weakness, tremors, or rapid heartbeat, often responds to sugary foods like candy, juice, or glucose tablets. However, always consult your doctor. Severe hypoglycemia can cause seizures or unconsciousness, requiring immediate emergency medical attention.
Store Basaglar 100 IU/ml KwikPens and unopened vials in the refrigerator (do not freeze). Unopened KwikPens are stable until the expiration date on the label. Keep all medication out of children's reach. Never use frozen or thawed Basaglar. If refrigeration isn't possible, store vials at room temperature, protected from light and heat. The solution should be clear, colorless, and particle-free.
Discuss insulin dose adjustments with your doctor. This is crucial if you're unwell (requiring closer blood sugar monitoring), taking other medications (which can interact with insulin), or experiencing changes in diet (eating less, skipping meals, or overeating). Your exercise, alcohol intake, and stress levels can also impact your blood sugar and insulin needs. Pregnant or breastfeeding individuals should consult their doctor before using Basaglar 100IU/ml Kwikpen, as dosage adjustments may be necessary.
Basaglar 100IU/ml KwikPen rarely causes serious side effects, though severe allergic reactions, characterized by rash, hives, itching, breathing difficulties (wheezing), rapid heart rate, and low blood pressure, are possible. Seek immediate medical attention if these occur. Other potential side effects include severe hypoglycemia (low blood sugar), manifesting as dizziness, sweating, anxiety, confusion, headache, blurred vision, slurred speech, tremors, rapid heartbeat, seizures, and unconsciousness. Concurrent use of TZDs (thiazolidinediones) may increase the risk of heart failure, even in individuals without pre-existing heart conditions. Sudden weight gain and ankle or foot swelling (edema) have also been reported. Report any of these side effects to your doctor promptly.
Basaglar 100IU/ml Kwikpen
698
MRP 769
9% off